CAS RN: 97267-61-3
7-BroMo-4-chloro-1,5-naph…
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
96% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260531
100mg / 250mg / 500mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 97267-61-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
97267-61-3 / 3-bromo-8-chloro-1,5-naphthyridine
Standard CAS: 97267-61-3
Multi CAS: No
Basic Information
copy
CAS
97267-61-3 copy
Multi CAS
No copy
Molecular Formula
C8H4BRCLN2 copy
Molecular Weight
243.490000 copy
Exact Mass
241.924640 copy
InChI
InChI=1S/C8H4BrClN2/c9-5-3-7-8(12-4-5)6(10)1-2-11-7/h1-4H copy
InChIKey
SKKJMLNKELECHI-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
10 copy
H-bond acceptors
2 copy
Molar refractivity
52.25 copy
TPSA
25.78 copy
LogP / Solubility
WLOGP
3.05 copy
MLOGP
2.69 copy
XLogP3
2.5 copy
Consensus LogP
2.75 copy
Log S (ESOL)
-3.89 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.76 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.77 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.04 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy